Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2016

Prognostic and Treatment Decision Implications of Exercise Induced Mitral Regurgitation

Presenter: Paul A. Grayburn, Patrizio Lancellotti

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2015

Exercise-Induced MR: Prognosis and Practicality

Presenter: Robert J. Siegel, Neil J. Weissman, Luc A Pierard

October 11, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Conference News TCT 2014

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

September 14, 2014

News Conference News TCT 2014

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

September 14, 2014

Presentation TCT 2014

Role of Exercise and Viability in the Evaluation of Mitral Regurgitation

Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Maurice E. Sarano

September 13, 2014

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

Presentation TCT 2013

PCI vs. Medical Therapy to Improve Exercise Capacity and Relieve Angina in SIHD: Prior Studies and Rationale for a New Randomized Trial

Presenter: Justin Davies

October 29, 2013

News Conference News TCT 2012

Novel Devices for Advanced HF on Horizon

October 26, 2012

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

Presentation TCT 2012

“Asymptomatic” Severe Aortic Stenosis: Use of Exercise Testing, Watchful Waiting vs. Early Valve Replacement

Presenter: Blase Carabello

October 22, 2012

News Conference News TCT 2012

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

October 22, 2012

Advertisement

Prognostic and Treatment Decision Implications of Exercise Induced Mitral Regurgitation

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Exercise-Induced MR: Prognosis and Practicality

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

Role of Exercise and Viability in the Evaluation of Mitral Regurgitation

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

PCI vs. Medical Therapy to Improve Exercise Capacity and Relieve Angina in SIHD: Prior Studies and Rationale for a New Randomized Trial

Novel Devices for Advanced HF on Horizon

Future Looks Bright for Stem Cell-Based Myocardial Therapy

“Asymptomatic” Severe Aortic Stenosis: Use of Exercise Testing, Watchful Waiting vs. Early Valve Replacement

Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content